What is the primary mechanism of action for selective estrogen receptor modulators (SERMs)?

• A. They block estrogen receptors in all tissues.
• B. They selectively activate or inhibit estrogen receptors in different tissues.
• C. They increase estrogen production in the ovaries.
• D. They inhibit the release of luteinizing hormone.

Answer: (B)

Selective estrogen receptor modulators (SERMs) function by selectively activating or inhibiting estrogen receptors in various tissues. This unique characteristic of SERMs allows them to produce estrogen-like effects in some tissues while blocking estrogenic activity in others.

For instance, in bone tissue, SERMs can mimic estrogen and help maintain bone density, which is beneficial in preventing osteoporosis. Conversely, in breast tissue, SERMs can act as antagonists, inhibiting estrogen effects that could lead to the growth of estrogen-sensitive tumors. This selective action is crucial for their therapeutic roles, which include treating conditions like breast cancer and osteoporosis, while minimizing risks associated with systemic estrogen exposure.

The other choices do not accurately represent the specific action of SERMs. Blocking estrogen receptors in all tissues would not allow for the beneficial effects seen in some tissues, and increasing ovarian estrogen production or inhibiting luteinizing hormone release are mechanisms associated with other types of hormonal therapies rather than the function of SERMs.